IL22 and staphylococcus aureus infection: By inserting the IL-22 gene into the previously constructed mammary tissue-specific expression plasmid, the range of action of IL-22 was limited, drug safety was improved, and Staphylococcus aureus infection was significantly reduced in vivo and in vitro.